Safety issues with drug therapies for autism spectrum disorders
- PMID: 16401148
Safety issues with drug therapies for autism spectrum disorders
Abstract
Although currently no medication has been approved to treat autism spectrum disorders, survey data show that community practitioners are prescribing a broad range of medication treatments, including, but not limited to, antidepressants, stimulants, antipsychotics, alpha agonists, and anticonvulsants. Patients with autism spectrum disorders are also taking alternative treatments, including herbal remedies, immunologic treatments, and vitamin therapies, which may themselves produce side effects and/or create drug interactions with traditional medications. Although short-term data on the efficacy and safety of commonly prescribed treatments for autism spectrum disorders are increasing, few data are currently available on long-term treatment for autism spectrum disorders, but available studies and clinical experience can offer preliminary recommendations on the safety of and monitoring needs for the medications currently used for these disorders. Monitoring the safety and tolerability of drugs used in patients with these disorders should minimize the burden of side effects and optimize treatment outcome.
Similar articles
-
Pharmacologic treatment of behavioral symptoms in autism and pervasive developmental disorders.J Clin Psychiatry. 2005;66 Suppl 10:26-31. J Clin Psychiatry. 2005. PMID: 16401147 Review.
-
Treatments for late-life bipolar disorder.Am J Geriatr Pharmacother. 2006 Dec;4(4):347-64. doi: 10.1016/j.amjopharm.2006.12.007. Am J Geriatr Pharmacother. 2006. PMID: 17296540 Review.
-
Pharmacologic treatment of pediatric insomnia.Child Adolesc Psychiatr Clin N Am. 2009 Oct;18(4):1001-16. doi: 10.1016/j.chc.2009.04.009. Child Adolesc Psychiatr Clin N Am. 2009. PMID: 19836701 Review.
-
Managing irritability and aggression in autism spectrum disorders in children and adolescents.Dev Disabil Res Rev. 2010;16(3):258-64. doi: 10.1002/ddrr.118. Dev Disabil Res Rev. 2010. PMID: 20981764 Review.
-
An update on pharmacologic treatments for autism spectrum disorders.Child Adolesc Psychiatr Clin N Am. 2006 Jan;15(1):161-75. doi: 10.1016/j.chc.2005.08.005. Child Adolesc Psychiatr Clin N Am. 2006. PMID: 16321729 Review.
Cited by
-
Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial.J Child Adolesc Psychopharmacol. 2015 Aug;25(6):482-93. doi: 10.1089/cap.2015.0005. J Child Adolesc Psychopharmacol. 2015. PMID: 26262903 Free PMC article. Clinical Trial.
-
Perspectives on the use of stem cells for autism treatment.Stem Cells Int. 2013;2013:262438. doi: 10.1155/2013/262438. Epub 2013 Oct 10. Stem Cells Int. 2013. PMID: 24222772 Free PMC article. Review.
-
Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings.J Neurodev Disord. 2012 Jul 6;4(1):19. doi: 10.1186/1866-1955-4-19. J Neurodev Disord. 2012. PMID: 22958744 Free PMC article.
-
Is Medication Information for Children with Autism Spectrum Disorder Monitored and Coordinated Across Professionals? Findings from a Teacher Survey.School Ment Health. 2013 Mar 1;5(1):48-57. doi: 10.1007/s12310-012-9098-5. Epub 2013 Feb 6. School Ment Health. 2013. PMID: 23526921 Free PMC article.
-
Progress of mesenchymal stem cell therapy for neural and retinal diseases.World J Stem Cells. 2014 Apr 26;6(2):111-9. doi: 10.4252/wjsc.v6.i2.111. World J Stem Cells. 2014. PMID: 24772238 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical